Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins

Research output: PatentScientific

Abstract

The present invention provides polypeptides that bind cellular receptors for vascular endothelial growth factor polypeptides; polynucleotides encoding such polypeptides; compositions comprising the polypeptides and polynucleotides; and methods and uses involving the foregoing. Some polypeptides of the invention exhibit unique receptor binding profiles compared to known, naturally occurring vascular endothelial growth factors.
Original languageEnglish
Publication Year2 Oct 2012
Publication statusPublished - 2 Oct 2012
MoE publication typeH1 Granted patent

Cite this

@misc{a8b88166acef42729c22414f57a33a19,
title = "Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins",
abstract = "The present invention provides polypeptides that bind cellular receptors for vascular endothelial growth factor polypeptides; polynucleotides encoding such polypeptides; compositions comprising the polypeptides and polynucleotides; and methods and uses involving the foregoing. Some polypeptides of the invention exhibit unique receptor binding profiles compared to known, naturally occurring vascular endothelial growth factors.",
author = "Alitalo, {Kari Kustaa} and Michael Jeltsch",
year = "2012",
month = "10",
day = "2",
language = "English",
publisher = "US Patent and Trademark Office",
address = "United States",
type = "Patent",
note = "US 8,278,098 B2",

}

Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins. / Alitalo, Kari Kustaa; Jeltsch, Michael.

US Patent and Trademark Office. Patent No.: US 8,278,098 B2. Oct 02, 2012.

Research output: PatentScientific

TY - PAT

T1 - Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins

AU - Alitalo, Kari Kustaa

AU - Jeltsch, Michael

PY - 2012/10/2

Y1 - 2012/10/2

N2 - The present invention provides polypeptides that bind cellular receptors for vascular endothelial growth factor polypeptides; polynucleotides encoding such polypeptides; compositions comprising the polypeptides and polynucleotides; and methods and uses involving the foregoing. Some polypeptides of the invention exhibit unique receptor binding profiles compared to known, naturally occurring vascular endothelial growth factors.

AB - The present invention provides polypeptides that bind cellular receptors for vascular endothelial growth factor polypeptides; polynucleotides encoding such polypeptides; compositions comprising the polypeptides and polynucleotides; and methods and uses involving the foregoing. Some polypeptides of the invention exhibit unique receptor binding profiles compared to known, naturally occurring vascular endothelial growth factors.

M3 - Patent

M1 - US 8,278,098 B2

Y2 - 2012/10/02

PB - US Patent and Trademark Office

ER -